Last reviewed · How we verify
NCT06640244
The Effect of Cosmetic Face Care Products on Facial Skin Tone and Spot Brightening
NA trial testing Sunscreen in Pigment Spots in 250 participants. Completed in 13 November 2025.
13 November 2025
Quick facts
| Lead sponsor | Unilever R&D |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 250 |
| Start date | 22 October 2024 |
| Primary completion | 13 November 2025 |
| Estimated completion | 13 November 2025 |
| Sites | 1 location across India |
Drugs / interventions tested
- Sunscreen — full drug profile →
- Cosmetic product G18
- Cosmetic product N70
- Cosmetic product D79
- Cosmetic product E84
- Cosmetic product C68
Conditions studied
- Pigment Spots — all drugs for Pigment Spots →
Sponsor
Unilever R&D — full company profile →
Who can join
Adults 20 to 45, female only, with Pigment Spots. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a single centre, 5-cell, blinded study to evaluate changes in even skin tone, skin glow, facial pigmented spots, and the microbiome of facial skin following the use of cosmetic face care products on the whole face over a 12 week period.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06640244
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Sunscreen
Trials testing the same drug.
- NCT07286318 — A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients · EARLY_PHASE1 · not yet recruiting
- NCT06366503 — Evaluating Procedure Pairing of a Post-Procedure Cream Versus a Comparator in Patients Treated With Fractional Ablative · NA · completed
- NCT05736224 — Assessing a Natural Product Plus Bioadhesive Nanoparticle (BNP) Sunscreen · Phase 1 · completed
- NCT06157853 — Evaluating Procedure Pairing of a Post-Procedure Cream Versus a Comparator in Patients Treated With a Radiofrequency Mic · NA · completed
- NCT05327361 — LiftActiv B3 in Post Inflammatory Hyperpigmentation (PIHP) · Phase 2 · terminated
Other Unilever R&D trials
Trials by the same sponsor.
- NCT06413810 — The Effects of a Food Ingredient on Self-reported Stress · NA · completed
- NCT05013801 — A Clinical Study to Evaluate the Effect of Facial Serum Q69 in Moderating the Appearance of Mild to Moderate Melasma · NA · completed
- NCT04155658 — Evaluation of Efficacy of Sodium Monofluorophosphate (SMPF) Toothpastes on Enamel Lesion Remineralisation · NA · completed
- NCT03953391 — The Effect of Tea Breaks on Cerebrovascular Perfusion During Desk Work · NA · completed
- NCT06800443 — A Cosmetic Study to Measure the Change in Tooth Colour After Using Instant Whitening Prototypes Compared to a Negative C · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06640244 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Unilever R&D
- Last refreshed: 17 November 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06640244.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing